Antengene announces nda for atg-010 (selinexor) granted priority review by china's nmpa

Shanghai and hong kong, feb. 23, 2021 /prnewswire/ -- antengene corporation limited ("antengene", sehk: 6996.hk), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology...
KPTI Ratings Summary
KPTI Quant Ranking